MD Anderson Cancer Center SC — Houston, Texas

MD Anderson Cancer Center SC is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center SC has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center SC?

MD Anderson Cancer Center SC has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center SC conducted?

MD Anderson Cancer Center SC has 2 clinical trials on record, with 1 currently active. Their work covers Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program, Diffuse Large B-cell Lymphoma (DLBCL).

Is MD Anderson Cancer Center SC accredited by Crixeo Health?

MD Anderson Cancer Center SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.